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Introduction
Brucellosis is a zoonotic disease caused by the Gram-negative genus Brucella (De Bolle et al. 2015) . Brucellosis remains endemic in many developing D r a f t Brucella melitensis M5-90△bp26 as a potential live vaccine 3 countries and causes substantial economic losses and public health risks (Franco et al. 2007 ). Currently, the most efficacious means of controlling brucellosis in animals is via live attenuated vaccines. However, difficulties in distinguishing immunizations from natural infections limits their application (Zhang et al. 2016) . Furthermore, an effective and safe human vaccine is currently unavailable, thus making the need for a low virulence and high efficacy vaccine urgent.
In China, the most widely used vaccine is the B. melitensis M5-90 attenuated live vaccine which was constructed by the China Harbin Veterinary Research Institute (Wang et al. 2013a) . After continuously attenuating a virulent Brucella strain in chickens, the M5 strain was developed. This strain was then passaged 90 times in chicken fibroblasts and a lower toxicity, high efficacy strain was developed (M5-90) (Wang et al. 2013b ). However, one disadvantage of this strain is an inability to distinguish a vaccine-based immunization from a natural infection (Wang et al. 
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Brucella melitensis M5-90△bp26 as a potential live vaccine 4 much weaker response than the virulent strains, with this difference being of practical significance when attempting to distinguish a natural infection and vaccine immunization (Yao et al. 2015) . Currently, the bp26 gene deleted vaccine strain and bp26 gene deletion can weaken Brucella virulence and provide better immunoprotection (Amani et al. 2015; Kim et al. 2013 ). The Rev.1 strain was selected from medium containing streptomycin and no streptomycin, toxicity is strong, have certain protective immunity of B.abortus and B. melitensis. However, as a vaccine is toxic, and the toxicity will be fully restored in a certain condition. M5-90 attenuated live vaccine is attenuated by the chicken, the virulence is weak, and there will be no toxicity recovery. Therefore, a better vaccine alternative will be obtained through the modification of the M5-90 vaccine strain. Furthermore, previous research has indicated that the S19 attenuated vaccines from the bp26 gene deletion mutant did not change its biological characteristics or the immunoprotectivity of the parental D r a f t D r a f t Brucella melitensis M5-90△bp26 as a potential live vaccine 6 modifications (Li et al. 2015a ). Primers were designed using the Brucella bp26 gene sequence (Genbank ID: AY065979) and its flanking sequences were upstream and downstream of the homologous arm (Table 1) . PCR amplification was performed to generate the 3 PCR products in addition to amplifying the sacB gene from Bacillus subtilis using primers sa-F and sa-R (Table 1) . The amplified sequences were cloned into the pMD19-T vector via Xba I/Nhe I and Nhe I/Sac I restriction sites. The upstream and downstream homologous arm sequences were cloned into the pGEM-7Zf + vector, followed by cloning of the SacB gene. Brucella vaccine strain M5-90 competent cells were transformed via electroporation and successful recombinants were selected via ampicillin resistance and a 5% sucrose screening.
M5-90△bp26 mutants were detected using appropriate primers (wb-F, wb-R and bp-F and bp-R) and compared with the M5-90 vaccine strain. The genetic stability of the M5-90△bp26 mutant was also established after 30 generations in culture.
Evaluation of M5-90△ △ △ △bp26 mutant attenuation in HPT-8 embryonic trophoblast cells HPT-8 embryonic trophoblast cells were seeded in 6-well plates and infected with M5-90△BP26 or the parental strain M5-90 at a multiplicity of infection (MOI) of 100 as previously described (Li et al. 2015b) . Culture plates were centrifuged at 350 × g for 5 min at room temperature and then placed at 37°C with 5% CO 2 . After 45 min post-infection, the cells were washed 3 times with medium and incubated for 1 h with 50 µg/mL of gentamicin (Invitrogen, USA) to kill any extracellular bacteria. The culture was then placed in DMEM containing 25 µg/mL gentamicin (defined as time D r a f t 7 zero). At different time points (0, 4, 8, 12, 24 and 48 h) post-infection, the supernatant was discarded and cells were lysed in PBST containing 0.1% (v/v) Triton X-100.
Bacteria used for enumeration were plated on TSA plates. All assays were performed in triplicate and repeated three times.
HPT-8 embryonic trophoblast cell cytotoxicity assay
HPT-8 embryonic trophoblast cells were cultured in 6-well plates for 3.5 h at 37°C in 5% CO 2 . Cells were then infected with M5-90 or M5-90∆bp26 at a MOI of 100, with supernatants collected at 24h post-infection. The HPT-8 cells were also infected with 60 µg/ml purified BP26 protein or PBS as a control. IL-6, IL-10 and TNF-α levels were determined in the supernatants via ELISA assay as previously described (Zhang et al. 2016) . Mice (n = 10 per time point per group) were euthanized by cervical dislocation 2 weeks post challenge, and bacterial CFUs in the spleens were determined as previously described (Li et al. 2015a 
Protection induced by M5-90△
Western blotting
Cell lysates containing the recombinant BP26 protein were analyzed by Western blotting as previously described (Li et al. 2015a 
BP26 protein Quantification
The purified protein was quantified using a BCA Protein kit (Sangon Biotech, China) according to the manufacture's protocols. The BP26 protein (25 µL) was combined with 200 µL BCA working solution, incubated for 30 min at 37°C and spectrophotometrically read at an absorbance of 562 nm. The BP26 protein concentration was then determined based on the generated BCA standard curve.
Establishment of an indirect ELISA method for BP26 protein
To determine optimal enzyme-conjugate secondary antibody concentration, with the maximum dilution positive serum reaction and OD 490nm value at 1.0% of the enzyme conjugate of the maximum dilution as enzyme conjugate (Table 3) .
Determination of the optimal coating antigen (purified recombinant BP26) and the concentration of serum dilution of positive and negative. ELISA plates were coated in either dilution purified recombinant BP26 antigen (3.2 mg/ml) or serum, with positive and negative serum diluted 1:10, 1:20, 1:40, 1:80 and 1:160 with matrix reaction (Table 4) . To determine the optimal serum dilution, a positive serum result was considered an OD 490nm > 1.0 and a negative serum result was considered an OD 490nm < 0.2. For the STAT, plain antigen was used as previously described (Islam et al. 2013 ).
Two-fold serial dilutions (1:25 to 1:200) of the serum were prepared in phenol saline (1150 µL of phenol saline was added to the first tube and 500 µL to the remaining tubes; then, 100 µL of serum was added to the first tube and mixed, 500 µL was transferred to the next tube and 750 µL was discarded; further volumes of 500 µL were transferred to subsequent tubes to give a series of double dilutions). Each tube then had 500 µL of STAT white antigen added, followed by the addition of 0.5 mL of plain antigen. After mixing, all the tubes were incubated at 37°C for 24 h. A titer of 1:50 or above was considered positive for brucellosis. 
Detection of serum samples from sheep
Statistical analysis
Bacterial survival in the HPT-8 cells and the mice is expressed as the mean LogCFU ± the standard deviation (SD). Antibody response and cytokine production are expressed as the mean OD 450 ± SD. RBPT and STAT were compared by using the Fisher test. The strain effect was further analyzed using a non-parametric
Kruskall-Wallis rank test. Results expressed as percentages were analyzed using the Fisher test. P-values < 0.05 were considered statistically significant.
Result
Construction of the B. Melitensis M5-90△ △ △ △bp26 mutant A B.melitensis strain M5-90 mutant (M5-90△bp26) was successfully constructed, with a 526 bp DNA fragment amplified when using the M5-90△bp26 primers (Table1). When M5-90 was amplified with the same primers, a 1279bp DNA fragment was generated, thus confirming successful knocked out (data not shown).
PCR products were sequenced to confirm the deletion and RT-PCR showed that bp26
was not transcribed in M5-90△bp26 mutant (data not shown).
M5-90△ △ △ △bp26 mutant is attenuated in HPT-8 embryonic trophoblast cells
To assess B. melitensis M5-90△bp26 attenuation, HPT-8 embryonic trophoblast cells were infected with the M5-90△bp26 mutant and compared with trophoblast
infected with other B. melitensis strains to assess replicative abilities. At 0 h and 4 h post-infection, no differences in bacterial loads were noted ( Fig.1) , thus indicating no significant difference in HPT-8 invasive abilities. However, 12 h post-infection, both strains experienced a 1.2-log (M5-90△bp26) and 0.3-log (M5-90) load decrease. At 24 h post-infection, the load had further decrease to 3.0-log and 0.7-log, respectively (P < 0.01; Fig.1 ). These results showed that the M5-90△bp26 mutant has a limited replicative ability in HPT-8 cells when compared with the vaccine strain M5-90, thus indicating that M5-90△bp26 is attenuated and that bp26 is involved in chronic Brucella infections.
M5-90△ △ △ △bp26 mutant is attenuated in BALB/c mice
To evaluate M5-90△bp26 virulence in vivo, BALB/c mice were intraperitoneally infected with 1 × 10 6 CFU of M5-90△bp26, M5-90 or PBS (negative control). To evaluate Brucella CFUs, mice spleens were evaluated 1, 3, 7, 14 and 28 days post-infection. While no significant difference in bacterial load was noted 1 and 3 days post-infection (P > 0.05), a 3.28-log decrease (P < 0.05) was noted in the M5-90△bp26 mutant compared to M5-90 ( Fig.2A) at day 7. At 14 days post-infection, a further decrease to 3.69-log was noted ( Fig.2A ; P < 0.05). These results showed that the M5-90△bp26 mutant was significantly attenuated (P < 0.05) at 7 and 14 days post-infection when compared to M5-90. Importantly, by 28 days post-infection, no detectable spleen CFU was detected in mice inoculated with M5-90△bp26 ( Fig.2A) . Additionally, when comparing splenic weights, the M5-90△bp26 infected spleens were significant lighter than that of M5-90 infected symptoms were more pronounced in the M5-90 inoculated group compared to the M5-90△bp26 group, but no deaths were noted in either group (Table 2a) . Furthermore, no significant differences in the growth rates were noted when compared to the PBS control. When the bacterial load was increased to 6 × 10 6 bacteria, a mortality rate of 50% was noted following M5-90 inoculation, while no mortality was noted in the M5-90△bp26 group (Table 2b) . When examining the growth rate, no significant difference was observed between the M5-90△bp26 group and the PBS control group, yet a slower rate was noted in the M5-90 group. Lastly, the mice were inoculated with 2 × 10 7 bacteria and a mortality rate 80% was noted in the M5-90 group, while no mortality was noted in the M5-90△bp26 mutant group (Table 2c) . When examining D r a f t the growth rate, no significant difference was observed between the M5-90△bp26 mutant group and the control, yet a slower rate was noted in the M5-90 group.
Determination of ELISA results
The optimal rabbit anti-sheep antibody dilution was found to be 1:20,000, with optimal defined as being able to react with the positive serum at a maximum dilution (OD 490nm ≥ 1) ( Table 3 ). To determine the optimal concentration of the coating BP26
antigen, the BP26 antigen was diluted to 1:500 and the negative and positive serum samples were diluted to 1:80. An OD 490nm ≥ 1 was considered a positive result and OD 490nm < 0.2 was considered negative (Table 4) . Thus, the optimal concentration of coating BP26 antigen was determined to be 6.4 µg/ml. To evaluate the determined concentrations, negative serum was obtained from 100 sheep and diluted 80 fold.
Average values and standard errors were determined at OD 490nm , with x + 2S determined to be the critical value of the negative serum and x being 0.211 and the value of S being 0.018, thus the critical value was 0.247. Therefore, serum samples at OD 490nm ≥ 0.247 were considered positive.
Comparison of the ELISA and test tube agglutination tests using sheep serum samples
As established, the coated BP26 antigen was diluted 1:500, the negative and positive serum were diluted 1:80 and the rabbit anti-sheep antibody diluted 1:20,000. potential serological interference that is associated with classical vaccines. Therefore, the ideal vaccine must be protective, non-virulent for the host and carrying a genetic marker (Moriyón et al. 2004) . Previous studies have shown that a bp26 mutant possesses reduced persistence in mice and that it induces superior protection, thus making it a new potential vaccine candidate against Brucellosis (Thavaselvam et al. 2010; Wen-Xing et al. 2011 ).
In the present study, a bp26 deletion mutant was constructed to confirm that the reduced survival capability of the mutant was directly related to the deleted bp26 phenotype (Osman et al. 2016) . However, it is difficult to differentiate between the serum of vaccinated animals and infected animals using these serological tests (Kianmehr et al. 2015) . Herein, serum from M5-90 inoculated mice tested D r a f t positive by RBPT and STAT, while M5-90△bp26 inoculated mice tested negative.
These results suggest that the BP26 protein may be useful in the development of a serological test able to differentiate the 2 strains.
High titers of serum were detected in sheep immunized with M5-90 vaccine strain after 7 days, but lower titers of serum were detected by STAT and RBPT in sheep after immunization M5-90△bp26 vaccine 21 days, M5-90△bp26 induced antibody production capacity is weak compared with the M5-90 strain (Table5), Possible reasons: First, the traditional STAT and RBPT are mainly for Brucella immune dominant S-LPS antigen, the lack of BP26 protein in this strain may be affect the expression of S-LPS antigen; Secondly, the dose of vaccines in this experiment were 1 × 10 9 CFU, for the significant decline in the virulence of the M5-90△bp26 strain, the dose may be too small, affecting the body's antibody expression; Thirdly, Brucella virulence and antigenicity are often positive correlation, the M5-90△bp26 strain virulence significantly reduced, affecting its survival and reproduction in macrophages, and Brucella invades the body mainly caused by infection-based immunity, intracellular survival, intracellular viability, causing decreased immunity, affecting the production of high titer antibodies. Clinical symptoms of the mice inoculated with the M5-90△bp26 
